Configurationally restricted bismacrocyclic CXCR4 receptor antagonists
Gina C Valks1, Graeme McRobbie, Elizabeth A Lewis
1Department of Chemistry and Clinical Biosciences Institute, University of Hull, Hull, HU6 7RX, United Kingdom.
A novel zinc(II) complex, a CXCR4 antagonist, shows a single configuration and binds acetate. This configurationally restricted compound is highly active against HIV infection in vitro.
Area of Science:
- Medicinal Chemistry
- Structural Biology
- Virology
Background:
- CXCR4 chemokine receptor antagonists are crucial for HIV therapy.
- Bismacrocyclic cyclam-type compounds offer a promising scaffold for antagonist development.
- Configurationally restricted analogues can improve target specificity and efficacy.
Purpose of the Study:
- To synthesize and characterize a zinc(II) containing, configurationally restricted analogue of bismacrocyclic cyclam-type CXCR4 antagonists.
- To elucidate the solution and solid-state structure of the synthesized compound.
- To evaluate the in vitro anti-HIV activity of the zinc(II) complex.
Main Methods:
- Synthesis of a novel zinc(II) bismacrocyclic complex.
- Single crystal X-ray diffraction for structural determination.
- In vitro anti-HIV assays.
Main Results:
- The synthesized zinc(II) complex exists in a single configuration in solution.
- X-ray crystallography revealed bidentate chelation with acetate, mimicking proposed receptor interactions.
- The zinc(II) complex demonstrated high activity against HIV infection in vitro.
Conclusions:
- Configurationally restricted zinc(II) bismacrocyclic complexes are effective CXCR4 antagonists.
- The observed binding mode provides insights into receptor-ligand interactions.
- This compound represents a potent new candidate for anti-HIV therapeutic strategies.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
Related Concept Videos
Antifungal Agents
GPCRs Regulate Adenylyl Cylase Activity
Two...
Inhibition of Cdk Activity
Cycloaddition Reactions: MO Requirements for Thermal Activation
The Antiviral System of Bacteria and Archaea: CRISPR
Antiviral Nucleoside Inhibitors
